top of page

Enstilar receives scientific approval in the EU for psoriasis

LEO Pharma has received scientific approval of Enstilar (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) in the European Union (EU) for the treatment of psoriasis vulgaris in patients 18 years of age or older.

Click on this link for more information.


Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page